Follow-Up Survey of the Impact of COVID-19 on People Living with HIV during the Second Semester of the Pandemic
Open Access
- 27 April 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (9) , 4635
Abstract
COVID-19 affects persons living with HIV (PLWH) both directly (via morbidity/mortality) and indirectly (via disruption of HIV care). From July–November 2020, an online survey was conducted to investigate the psychosocial well-being of PLWH and changes in HIV care during the second semester of the COVID-19 outbreak. Data were collected on the socio-demographic characteristics of PLWH, their psychosocial well-being, impact of COVID-19 preventive measures on their daily routines and HIV follow-up. Of the 247 responses analyzed (mean age: 44.5 ± 13.2 years; 73.7% male), 67 (27.1%) and 69 (27.9%) respondents screened positive for anxiety (GAD-2 score ≥ 3) and depression (PHQ-2 score ≥ 3), respectively. HIV care had returned to pre-COVID-19 state for 48.6% PLWH, and 108 (43.7%) had no HIV follow-up during the past month. Over three quarters (76.1%) of respondents expressed willingness to receive the COVID-19 vaccine. Compared to previous findings in April 2020, substance use increased from 58.6% to 67.2% (p < 0.001). Our findings suggest that the well-being and medical follow-up of PLWH are still affected after almost a year into the COVID-19 outbreak. Remote HIV follow-up (telemedicine) with psychosocial support should be envisaged in the medium to long-term. Given that most PLWH accept COVID-19 vaccination, they may be prioritized for this intervention.Keywords
Funding Information
- H2020 European Research Council (671055)
- Vlaamse Interuniversitaire Raad (NA)
This publication has 28 references indexed in Scilit:
- Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?AIDS Patient Care and STDs, 2020
- Maintaining HIV care during the COVID-19 pandemicThe Lancet HIV, 2020
- Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain InjuryJournal of Affective Disorders, 2020
- Toward the realization of cardiac regenerative medicine using pluripotent stem cellsInflammation and Regeneration, 2020
- Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysisBMJ Supportive & Palliative Care, 2019
- Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literatureClinical Psychology Review, 2017
- Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studiesBJPsych Open, 2016
- The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary careBMJ Evidence-Based Medicine, 2007
- Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and DetectionAnnals of Internal Medicine, 2007
- The Patient Health Questionnaire-2Medical Care, 2003